Skip to main content

Table 3 Treatment during hospitalization, US cohort. Cells show the percentage and numerator / denominator in round brackets

From: Race and ethnicity in the COVID-19 Critical Care Consortium: demographics, treatments, and outcomes, an international observational registry study

 

Dialysis

ECMO

HF Nasal Oxygen

Invasive Mechanical Ventilation

Non-invasive Mechanical Ventilation

American Indian or Alaska Native

42% (24/57)

23% (13/57)

91% (52/57)

89% (51/57)

49% (28/57)

Asian

20% (5/25)

34% (10/29)

64% (16/25)

84% (21/25)

60% (15/25)

Black

28% (107/381)

22% (83/381)

61% (228/371)

63% (241/382)

41% (156/379)

Hispanic or Latino

23% (51/220)

43% (100/231)

71% (156/220)

79% (175/221)

40% (87/220)

Native Hawaiian or Other Pacific Islander

40% (2/5)

50% (3/6)

60% (3/5)

80% (4/5)

80% (4/5)

Unanswered

22% (15/69)

32% (22/69)

51% (34/67)

77% (53/69)

29% (20/69)

Other

34% (10/29)

52% (16/31)

41% (12/29)

90% (26/29)

43% (12/28)

White

26% (118/457)

23% (105/462)

64% (287/449)

72% (332/459)

44% (203/457)

  1. Treatments during hospitalization, US Cohort, by ethnicity. The cells show the percentage of patients who had the specified treatment at any point in their hospital stay. The numerator and denominator under each percentage are the number of patients who had the treatment and the number of patients who had a yes or no response in the case report form for the designated treatment, respectively